127 related articles for article (PubMed ID: 2223683)
1. Hormone implants and tachyphylaxis.
Garnett T; Studd JW; Henderson A; Watson N; Savvas M; Leather A
Br J Obstet Gynaecol; 1990 Oct; 97(10):917-21. PubMed ID: 2223683
[TBL] [Abstract][Full Text] [Related]
2. An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy.
Buckler HM; Kalsi PK; Cantrill JA; Anderson DC
Clin Endocrinol (Oxf); 1995 May; 42(5):445-50. PubMed ID: 7621560
[TBL] [Abstract][Full Text] [Related]
3. Associations of hormones and menopausal status with depressed mood in women with no history of depression.
Freeman EW; Sammel MD; Lin H; Nelson DB
Arch Gen Psychiatry; 2006 Apr; 63(4):375-82. PubMed ID: 16585466
[TBL] [Abstract][Full Text] [Related]
4. An audit of oestrogen implant hormone replacement therapy.
Templeman C; Quinn D; Hansen R; Moreton T; Baber R
Aust N Z J Obstet Gynaecol; 1998 Nov; 38(4):455-60. PubMed ID: 9890234
[TBL] [Abstract][Full Text] [Related]
5. Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy?
Pearlstein TB
Am J Obstet Gynecol; 1995 Aug; 173(2):646-53. PubMed ID: 7645647
[TBL] [Abstract][Full Text] [Related]
6. Premenstrual depression, cortisol and oestradiol treatment.
Crammer JL
Psychol Med; 1986 May; 16(2):451-5. PubMed ID: 3014589
[TBL] [Abstract][Full Text] [Related]
7. 25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?
Owen EJ; Siddle NC; McGarrigle HT; Pugh MA
Br J Obstet Gynaecol; 1992 Aug; 99(8):671-5. PubMed ID: 1327094
[TBL] [Abstract][Full Text] [Related]
8. Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants.
Naessén T; Persson I; Thor L; Mallmin H; Ljunghall S; Bergström R
Br J Obstet Gynaecol; 1993 May; 100(5):454-9. PubMed ID: 8518246
[TBL] [Abstract][Full Text] [Related]
9. Clinical audit of estradiol implant therapy: Long duration of action and implications in non-hysterectomised women.
Wheatley S; Bell RJ; Stuckey BG; Robinson PJ; Davis SR
Maturitas; 2016 Dec; 94():84-86. PubMed ID: 27823750
[TBL] [Abstract][Full Text] [Related]
10. Treatment of menopausal oestrogen deficiency symptoms in hysterectomised women by means of 17beta-oestradiol pellet implants.
Staland B
Acta Obstet Gynecol Scand; 1978; 57(3):281-5. PubMed ID: 665176
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen therapy for the menopause.
Studd J; Watson N; Henderson A
Br J Psychiatry; 1990 Dec; 157():931-2. PubMed ID: 2289110
[No Abstract] [Full Text] [Related]
12. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
Soares CN; Almeida OP; Joffe H; Cohen LS
Arch Gen Psychiatry; 2001 Jun; 58(6):529-34. PubMed ID: 11386980
[TBL] [Abstract][Full Text] [Related]
13. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy.
Panay N; Versi E; Savvas M
BJOG; 2000 Aug; 107(8):1012-6. PubMed ID: 10955434
[TBL] [Abstract][Full Text] [Related]
14. Circulating dehydroepiandrosterone-sulphate decreases even with a slight change in oestradiol.
Matsui S; Yasui T; Kasai K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
J Obstet Gynaecol; 2018 Feb; 38(2):231-235. PubMed ID: 28903616
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy for reproductive depression in women.
Studd J
Post Reprod Health; 2014 Dec; 20(4):132-7. PubMed ID: 25398672
[TBL] [Abstract][Full Text] [Related]
16. Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants.
File SE; Heard JE; Rymer J
Psychopharmacology (Berl); 2002 Apr; 161(1):107-12. PubMed ID: 11967638
[TBL] [Abstract][Full Text] [Related]
17. Adequacy of hormone replacement therapy for osteoporosis prevention assessed by serum oestradiol measurement, and the degree of association with menopausal symptoms.
Rodgers M; Miller JE
Br J Gen Pract; 1997 Mar; 47(416):161-5. PubMed ID: 9167320
[TBL] [Abstract][Full Text] [Related]
18. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study.
Pearce J; Hawton K; Blake F; Barlow D; Rees M; Fagg J; Keenan J
J Psychosom Res; 1997 Feb; 42(2):177-86. PubMed ID: 9076645
[TBL] [Abstract][Full Text] [Related]
19. The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants.
Studd J; Savvas M; Waston N; Garnett T; Fogelman I; Cooper D
Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1474-9. PubMed ID: 2240090
[TBL] [Abstract][Full Text] [Related]
20. Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants.
Gangar K; Cust M; Whitehead MI
BMJ; 1989 Sep; 299(6699):601-2. PubMed ID: 2508819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
